KORU Medical Systems, Inc. (KRMD) Fair Value 2026

KRMD · Surgical & Medical Instruments & Apparatus ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

6.5 /10

32 fundamental signals · 12 models active

Value Trap Risk

SAFE (6/100)

Quick Summary — As of 2026-07-13, KORU Medical Systems, Inc. (KRMD) trades at $4.23, approximately 277% above CirclFi’s Bayesian DCF fair value of $1.12. QOC: 6.5/10. Value Trap Risk: 6/100 (SAFE). 12/13 models active.

Key Facts

Ticker
KRMD
Price
$4.23
Quality Score
6.5/10
Value Trap Risk
6/100
Models Active
12/13
Last Updated
Strength: 12 independent models provide multi-angle coverage
Risk: Majority of models suggest overvaluation

Valuation Matrix

12 Intrinsic Value Models vs. Current Price ($4.23)

Core Models (Unlocked)
Model Fair Value Upside
Bayesian DCF
Low Conviction
$1.12 -73.5%
Earnings Power Value
Low Conviction
$1.13 -73.3%
CUCE Ensemble
Low Conviction
$1.29 -69.6%
First Chicago
Low Conviction
$1.60 -62.1%

Unlock the Full Matrix

Access 8 additional models including EROIC Spread, Markov DDM, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 12 Models →

Cancel anytime · No contracts · Instant access

What Is KORU Medical Systems, Inc. (KRMD) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, KORU Medical Systems, Inc.'s intrinsic value is estimated at $1.54. Trading at its current price of $4.23, the valuation engine raises significant caution: 12 of 12 models flag downside risk, projecting an average implied return of -63.5%. Model dispersion is worth noting: PWERM targets $3.84 (-9.3%), versus ML-RIV at $0.05 (-98.8%). This +89.5% range highlights the importance of multi-model analysis rather than relying on any single methodology.

What Do the Models Say About KRMD?

12 of 13 models are currently active for KRMD. All 12 active models suggest the stock trades above fair value. The Bayesian DCF estimates KRMD's intrinsic value at $1.12, implying -73.5% downside from the current price. See which stocks rank higher →

How Does KRMD Rank in Surgical & Medical Instruments & Apparatus?

Among 111 Surgical & Medical Instruments & Apparatus stocks, KRMD ranks #56 by Quality of Company score. CirclFi's QOC score of 6.5/10 evaluates 32 fundamental signals. A score of 6.5 indicates above-average quality.

See all Most Undervalued Surgical & Medical Instruments & Apparatus Stocks →

KORU Medical Systems, Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is KRMD a Value Trap?

CirclFi's Value Trap algorithm assigns KRMD a score of 6/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

12 of 13 models are active for KORU Medical Systems, Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Deep Alpha Valuation Engine, KORU Medical Systems, Inc. scores 6.5 out of 10 on our 32-signal quality assessment, a solid rating that maintains reasonable quality metrics with some areas for improvement. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.

The gap between the most bullish and bearish model spans +89.5% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every KRMD valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across KRMD's 12 active models, average confidence is 21%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy KORU Medical Systems, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Surgical & Medical Instruments & Apparatus Stocks Should You Also Analyze?

8 related Surgical & Medical Instruments & Apparatus stocks with 13-model coverage

Read investment analysis: DXCM · IRMD · PODD · RMD · WST

See all Surgical & Medical Instruments & Apparatus stocks ranked →

Frequently Asked Questions About KORU Medical Systems, Inc.

What is KORU Medical Systems, Inc.'s intrinsic value in 2026?

Based on CirclFi's 13-model analysis, KORU Medical Systems, Inc. (KRMD) has multiple fair value estimates. The Bayesian DCF model runs 10,000 Monte Carlo simulations with jump-diffusion to estimate intrinsic value at $1.12. The Quality of Company score is 6.5/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is KRMD overvalued or undervalued right now?

At $4.23, 0 of 12 active models suggest KRMD may be undervalued, while 12 indicate potential overvaluation. The assessment depends on which methodology best fits KORU Medical Systems, Inc.'s business model in Surgical & Medical Instruments & Apparatus.

What does a Quality of Company score of 6.5 mean for KRMD?

KORU Medical Systems, Inc.'s QOC of 6.5/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on KRMD?

CirclFi analyzes KRMD with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 12 of 13 are active for this stock. Read the full methodology →

Is KRMD a value trap in 2026?

KORU Medical Systems, Inc.'s Value Trap score is 6/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 12 mathematical frameworks give you clarity on KRMD.

Unlock All 12 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access